Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 7/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.81 |
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.59 |
| ▸ | TTR | P02766 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dinitro Cresol SCHEMBL10801726 | 0.94 | GPR35 (0.76) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL9221013 | 0.90 | ALDH1A1 (0.81) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL1716451 | 0.90 | GPR35 (0.93) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL8873755 | 0.90 | GPR35 (1.00) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL29430312 | 0.90 | GPR35 (1.00) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL20734 | 0.90 | GPR35 (1.00) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL3976321 | 0.89 | GPR35 (0.78) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL892354 | 0.89 | ALDH1A1 (0.78) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL4636121 | 0.89 | ALDH1A1 (0.78) | GPR35ALDH1A1MAPTHPGDKDM4E | |
| Dinitro Cresol SCHEMBL1509581 | 0.89 | GPR35 (0.78) | GPR35ALDH1A1MAPTHPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008045017-A2 | SARS AND EBOLA INHIBITORS AND USE THEREOF, AND METHODS FOR THEIR DISCOVERY | DIAMOND SCOTT L (US) | 2008-04-17 | — | — | WO | disclosed |
| US-20070203073-A1 | SARS and Ebola inhibitors and use thereof, and methods for their discovery | DIAMOND SCOTT L | 2007-08-30 | — | — | US | disclosed |
| EP-0623134-B1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | UNIV TEXAS (US) | 2002-11-06 | — | — | EP | disclosed |
| US-5994535-A | Water soluble texaphyrin metal complex preparation | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1999-11-30 | — | — | US | disclosed |
| US-5733903-A | ANTITUMOR AGENTS WITH DIAMAGNETISM | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-03-31 | — | — | US | disclosed |
| US-5569759-A | MAGNETIC RESONANCE IMAGING; TUMOR THERAPY | BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) | 1996-10-29 | — | — | US | disclosed |
| US-5504205-A | MACROMOLECULAR PORPHYRINS; WATER SOLUBILITY, LIPOPHILIC | BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (US) | 1996-04-02 | — | — | US | disclosed |
| US-5475104-A | Useful in magnetic resonance imaging; detection tumors, cancer cells; transition and lanthanide metals | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-12-12 | — | — | US | disclosed |
| US-5457183-A | Radiosensitizers | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-10-10 | — | — | US | disclosed |
| US-5451576-A | Tumor imaging and treatment by water soluble texaphyrin metal complexes | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-09-19 | — | — | US | disclosed |
| US-5439570-A | Destroying tumors, viruses; magnetic resonance imaging | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-08-08 | — | — | US | disclosed |
| US-5432171-A | Water soluble texaphyrin metal complexes for viral deactivation | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1995-07-11 | — | — | US | disclosed |
| EP-0623134-A1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1994-11-09 | — | — | EP | disclosed |
| US-5252720-A | Medical uses | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-10-12 | — | — | US | disclosed |
| WO-1993014093-A1 | METAL COMPLEXES OF WATER SOLUBLE TEXAPHYRINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1993-07-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203073-A1 | SARS and Ebola inhibitors and use thereof, and methods for their discovery | CTSL, CTSV, CTSZ | GPR35 4381/4885ALDH1A1 2172/4885MAPT 3097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.